Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

Vivos Therapeutics, Inc

Contributing Author

Recent Articles by Vivos Therapeutics, Inc

Aug-28
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center VVOS -12.96% GlobeNewswire
Aug-25
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers VVOS GlobeNewswire
Aug-20
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment VVOS GlobeNewswire
Aug-14
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update VVOS +12.45% VVOS -12.26% GlobeNewswire
Aug-14
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call VVOS +12.45% GlobeNewswire
Aug-11
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations VVOS GlobeNewswire
Aug-05
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology VVOS -26.31% GlobeNewswire
Jun-30
Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants VVOS -7.81% GlobeNewswire
Jun-22
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity VVOS -19.56% GlobeNewswire
Jun-11
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering VVOS GlobeNewswire
Jun-10
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients VVOS -8.75% GlobeNewswire
Jun-08
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 VVOS VVOS -19.52% GlobeNewswire
Jun-05
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing VVOS +24.84% GlobeNewswire
May-20
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update VVOS GlobeNewswire
Apr-15
Vivos Therapeutics Reports Full Year 2025 Financial Results VVOS +8.89% VVOS -25.85% GlobeNewswire
Apr-15
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call VVOS +8.89% GlobeNewswire
Apr-07
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners VVOS -5.34% GlobeNewswire
Mar-26
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market VVOS GlobeNewswire
Mar-17
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy VVOS GlobeNewswire
Feb-05
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies VVOS GlobeNewswire
Jan-20
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds VVOS VVOS -7.11% GlobeNewswire
Jan-16
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds VVOS GlobeNewswire
Dec-16
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan VVOS GlobeNewswire
Dec-15
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST VVOS GlobeNewswire
Nov-19
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025 VVOS VVOS -10.17% GlobeNewswire
Nov-19
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Sep-30
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device VVOS GlobeNewswire
Sep-17
Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment VVOS GlobeNewswire
Aug-19
Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update VVOS GlobeNewswire
Aug-19
Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Jul-30
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth VVOS GlobeNewswire
Jul-01
Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance VVOS +22.47% GlobeNewswire
Jun-26
New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children VVOS +10.49% GlobeNewswire
Jun-11
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada VVOS +5.21% GlobeNewswire
May-15
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update VVOS VVOS -16.99% GlobeNewswire
May-14
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call VVOS GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)